+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Age: 18Years - 75Years
All Genders
ID06897228

Exploring Safety and Effectiveness of PANK-003 Cell Injection with Standard Chemotherapy After Surgery in Adults with Solid Tumors

Led by Shenzhen Celconta Life Science Co., Ltd. · Updated on 2025-03-26

18

Participants Needed

1

Research Sites

8 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying the safety, tolerability, and preliminary effectiveness of PANK-003 cell injections combined with standard adjuvant chemotherapy in patients who have undergone surgery for solid tumors such as lung, esophageal, gastric, and breast cancers. This is a single-center, single-arm, dose-escalation exploratory clinical trial focused on adult patients after surgery and chemotherapy. The study aims to find the best dose and assess side effects of this cell therapy in this patient group. Participants will receive multiple injections of the PANK-003 cell preparation alongside their standard postoperative chemotherapy as part of the treatment period. The study includes a screening phase, the treatment phase with cell injections, and an observation and follow-up phase to monitor outcomes. The trial evaluates dose limiting toxicity, treatment-related adverse events, and maximum tolerated dose within 21 days after each administration. During the study, participants will be monitored for safety and treatment effects including disease-free survival and overall survival over one year. Assessments include laboratory tests, imaging, and clinical evaluations to track side effects and cancer status. The total study participation spans from initial screening through treatment and up to one year of follow-up to observe long-term safety and outcomes.

CONDITIONS

Brief Title

PANK-003 Cell Injection Combined with Standard Adjuvant Chemotherapy After Surgery in Patients with Solid Tumors

Research Team

B

Baozhong Li

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here